ADVANCING Brain

DIAGNOSTICS

A cell-specific exosome diagnostic platform providing a noninvasive, inexpensive, and robust diagnostic tool.

 

 

OUR VISION

At NeuroDex, we envision a world where dementia pathology is understood and patients receive personalized treatments according to their pathology 

Our proprietary neuron-derived exosome isolation technology can be applied across a number of neurological indications. With our technology, a simple blood draw could allow physicians for a brain liquid biopsy

Our lead indication is Lewy Body Dementia, a poorly understood disease comprising between 6%-20% of all dementias 

 

THE 
NEURODEX 
ADVANTAGE

Increasing signal to noise ratio by utilizing cell specific exosomes, has shown an increase of over 20 fold

QUICK-TO-MARKET

 

Leveraging regulatory FDA framework for Lab- Developed-Tests creates a quick to-market-opportunity

PLATFORM TECHNOLOGY

Capturing neuron derived exosomes enables identification of diverse pathological aspects

SAMPLE FLEXIBILITY

 

Use of frozen samples enables utilization of retrospective biobanks

TARGETED

 

Our data demonstrates a robust and high precision platform

SYNERGISTIC

 

We offer an isolation platform that can be combined with different detection methodologies

TEAM EXPERTISE

 

We have industry and academic experience in public and private diagnostic companies

OUR TEAM

Erez Eitan
EREZ EITAN
CSO, Co-founder
Dr. Eitan was the first to study exosome...
ODED BIRAN
CEO, Co-founder
Oded is an experienced diagnostics execu...
CHRISTINA MENDONCA
Controller
Christina  is a Certified Public Account...
 
papers-lighten_edited.jpg

PUBLICATIONS FROM OUR TEAM

2021

Neuronal and Astrocytic Extracellular Vesicle Biomarkers in
Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s
Disease

2019

Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging

2017

Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes

2017

In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles

2017

Walking speed decline in older adults is associated with elevated pro-BDNF in plasma extracellular vesicles

2016

Extracellular Vesicle-Associated Aβ Mediates Trans-Neuronal Bioenergetic and Ca2+-Handling Deficits in Alzheimer's Disease Models

2015

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study

 

CONTACT

US

Please contact us with inquiries and questions at info@neurodex.co